Cointime

Maze Therapeutics

company

About

Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

  • 101 - 250

Highlights

Total Funding Amount
$381M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$190M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
101 - 250
Operating Status
Active

Maze Therapeutics is a biotechnology firm used to focus on translating genetic insights into new medicines. The company's translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, functional genomics, and an array of drug discovery approaches. and it also reveals modifier genes that confer protection and provide a deeper understanding of the target biology and how these targets can be targeted with drug therapies, enabling patients with protection against diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$381M
Maze Therapeutics has raised a total of $381M in funding over 2 rounds. Their latest funding was raised on Jan 10, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 10, 2022 Series Unknown $190M 1 — — Detail
Feb 28, 2019 Series A $191M 1 ARCH Venture Partners — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Maze Therapeutics is funded by 2 investors. ARCH Venture Partners and General Catalyst are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Yes Series A
General Catalyst — Series Unknown
Cointime
เนื้อหา
บริษัท